Aviva
CDNA icon

Aviva’s CareDx CDNA Stock Holding History

Aviva’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,132
Closed -$511K – 880
2025
Q2 		$511K Buy
26,132
+4,317
+20% +$76.7K ﹤0.01% 722
2025
Q1 		$387K Buy
+21,815
New +$470K ﹤0.01% 824

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Aviva's CDNA Position: Q3 2025 in Review

Aviva sold out of CareDx (CDNA) in Q3 2025, closing a stake of 26,132 shares — an estimated $511K sold.

Aviva first reported a position in CDNA in Q1 2025 and held it in 2 quarters. The position peaked at $511K in Q2 2025. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Aviva reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Aviva sold 26,132 CareDx shares in Q3 2025, an estimated $511K.
  • Aviva first reported a position in CareDx in Q1 2025 and held it in 2 quarters.
  • Aviva's CareDx position peaked at $511K in Q2 2025.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.